Pfizer in break up talks for Sandwich research site
March 1, 2011Research and Development Kent, Pfizer, Sandwich, job cuts
Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …
Service Insight: Discovery metrics – creating the right balance
February 28, 2011Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development
SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …
David Redfern appointed ViiV chairman
February 28, 2011Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing
David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
Black Swan Analysis appoints Luke McDermott
February 28, 2011Sales and Marketing Black Swan Analysis, Luke McDermott, appointment, sales and marketing
Maidenhead, UK-based Black Swan Analysis has expanded its analysis and forecasting team with the appointment of Luke McDermott.He joins the …
AZ opens new global HQ in London
February 28, 2011Medical Communications, Sales and Marketing AZ, AstraZeneca, London
AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …
Healthcare IT and patients: lessons from the NHS experience
February 28, 2011Medical Communications, Sales and Marketing Healthcare IT, NHS, NHS IT, electronic patient records, online health information
Many countries are investing heavily in electronic health records and health information exchange to drive improvements in the quality of …
Vertex’s cystic fibrosis drug shows huge promise
February 28, 2011Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis
US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …
New agreement seeks to speed up UK research
February 25, 2011Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA
The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
MPs to question Pfizer management over R&D closure
February 25, 2011Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development
Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …
Virgo Health boosts consultancy team
February 25, 2011Medical Communications Caroline Gosling, Vantage, Virgo, Virgo Health PR, appointment, medical communications
Former Virgo Health PR managing director Caroline Gosling has moved to the company’s consultancy arm Vantage. She takes on a …
Sanofi picks two agencies for UK diabetes account
February 25, 2011Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health
Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …
Cally Clarkson joins HealthEd
February 25, 2011Medical Communications Cally Clarkson, HealthEd, appointment, medical communications
Cheshire, UK-based medical education agency HealthEd has appointed Cally Clarkson as client services director. She has 10 years of healthcare …
Retaining pharma top talent
February 25, 2011Business Services MedImmune, careers, recruitment, talent retention
Strategies to co-ordinate talent retention differ between companies, and they may not always be as forward-focused as they could – …
Glioblastoma vaccine enters phase II
February 24, 2011Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology
The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
Digital Pharma: Sanofi shifts video focus to YouTube
February 24, 2011Medical Communications Digital Pharma blog, Sanofi-Aventis, online pharma video, youtube
Sanofi-Aventis has scaled back its online video ambitions and moved its web TV channel to YouTube. The move sees the …
Working Life: BMS UK’s market access director Patrick Hopkinson
February 24, 2011Business Services, Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, Patrick Hopkinson, Working Life, recruitment
Patrick Hopkinson, director of market access and external affairs at Bristol-Myers Squibb UK, talks to Pharmafocus about how he got …
Minesh Ghelani joins Astralis Group
February 24, 2011Business Services Astralis Group, Mishesh Ghelani, appointment, business services
Recruitment consultancy Astralis has appointed Minesh Ghelani as a senior consultant to its Life Sciences Practice.After obtaining his degree in …
Abbott wins $1.7bn Humira case
February 24, 2011Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis
Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …
50,000 NHS jobs to be cut
February 24, 2011False Economy, GPs, NHS, NHS reforms, TUC, nurses
NHS trusts are preparing to make a major series of job cuts as the health service wrestles with the need …
Red Door boosts management team
February 24, 2011Medical Communications Laura Clark, Liz Adams, Red Door Communications, appointment, medical communications
Red Door Communications has appointed its first `home grown’ consultant to its management team. Laura Clark has been made an …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
